COLRAIN CAPITAL LLC - Q2 2021 holdings

$53.1 Million is the total value of COLRAIN CAPITAL LLC's 24 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was - .

 Value Shares↓ Weighting
VRTX NewVertex Pharmaceuticals Incetf$1,673,0008,300
+100.0%
3.01%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CVS HEALTH CORP38Q3 20229.6%
APPLE INC38Q3 20229.0%
MICROSOFT CORP38Q3 20228.3%
HESS CORP COM38Q3 20227.8%
COMCAST CORP NEW CL A38Q3 20225.5%
THE MOSAIC COMPANY COMMON38Q3 202211.5%
INTL PAPER CO COM38Q3 20226.0%
CITIGROUP INC COM NEW38Q3 20225.9%
ABBVIE INC SHS38Q3 20225.8%
BERKSHIRE HATHAWAYINC DEL CL38Q3 202225.4%

View COLRAIN CAPITAL LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-11
13F-HR2022-02-07
13F-HR2021-11-15
13F-HR2021-08-13
13F-HR/A2021-05-10
13F-HR2021-04-30
13F-HR2021-02-02
13F-HR2020-11-12

View COLRAIN CAPITAL LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (53056000.0 != 55583000.0)

Export COLRAIN CAPITAL LLC's holdings